Get Real Time Here
| Open0.981 | Close- |
| Vol / Avg.15.635K / 130.124K | Mkt Cap4.946M |
| Day Range0.940 - 1.000 | 52 Wk Range0.980 - 20.885 |
Windtree Therapeutics Stock (NASDAQ:WINT), Quotes and News Summary
Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
| Open0.981 | Close- |
| Vol / Avg.15.635K / 130.124K | Mkt Cap4.946M |
| Day Range0.940 - 1.000 | 52 Wk Range0.980 - 20.885 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -1.640 | -0.9600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-06-04 | Oppenheimer | Leland Gershell | Initiates Coverage On | Outperform | Announces | - | 8.00 |
| 2020-06-26 | Ladenburg Thalmann | Jeffrey Cohen | Initiates Coverage On | Buy | Announces | - | 12.25 |
| 2017-06-30 | Stifel | Thomas Shrader | Downgrades | BuyHold | - | - | - |
| 2016-04-22 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| WINT | Windtree Therapeutics | -2.06% | 4.9M |
| QNRX | Quoin Pharmaceuticals | -4% | 4.7M |
| ADXN | Addex Therapeutics | -10.03% | 5.6M |
| CYCC | Cyclacel Pharmaceuticals | -5.33% | 4M |
| NEXI | NexImmune | -3.43% | 5.3M |
How do I buy Windtree Therapeutics (WINT) stock?
You can purchase shares of Windtree Therapeutics (NASDAQ: WINT) through any online brokerage.
Who are Windtree Therapeutics's (WINT) competitors?
Other companies in Windtree Therapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC), NexImmune (NASDAQ:NEXI) and Biophytis (NASDAQ:BPTS).
What is the target price for Windtree Therapeutics (WINT) stock?
The latest price target for Windtree Therapeutics (NASDAQ: WINT) was reported by Oppenheimer on Friday, June 4, 2021. The analyst firm set a price target for 8.00 expecting WINT to rise to within 12 months (a possible 732.64% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Windtree Therapeutics (WINT)?
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $0.9608 last updated Today at September 22, 2023 at 6:05 PM UTC.
Does Windtree Therapeutics (WINT) pay a dividend?
There is no dividend information for Windtree Therapeutics.
When is Windtree Therapeutics (NASDAQ:WINT) reporting earnings?
Windtree Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Windtree Therapeutics (WINT) going to split?
There is no upcoming split for Windtree Therapeutics.
What sector and industry does Windtree Therapeutics (WINT) operate in?
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Windtree Therapeutics Stock (NASDAQ:WINT), Quotes and News Summary
Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
| Open0.981 | Close- |
| Vol / Avg.15.635K / 130.124K | Mkt Cap4.946M |
| Day Range0.940 - 1.000 | 52 Wk Range0.980 - 20.885 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -1.640 | -0.9600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-06-04 | Oppenheimer | Leland Gershell | Initiates Coverage On | Outperform | Announces | - | 8.00 |
| 2020-06-26 | Ladenburg Thalmann | Jeffrey Cohen | Initiates Coverage On | Buy | Announces | - | 12.25 |
| 2017-06-30 | Stifel | Thomas Shrader | Downgrades | BuyHold | - | - | - |
| 2016-04-22 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| WINT | Windtree Therapeutics | -2.06% | 4.9M |
| QNRX | Quoin Pharmaceuticals | -4% | 4.7M |
| ADXN | Addex Therapeutics | -10.03% | 5.6M |
| CYCC | Cyclacel Pharmaceuticals | -5.33% | 4M |
| NEXI | NexImmune | -3.43% | 5.3M |
How do I buy Windtree Therapeutics (WINT) stock?
You can purchase shares of Windtree Therapeutics (NASDAQ: WINT) through any online brokerage.
Who are Windtree Therapeutics's (WINT) competitors?
Other companies in Windtree Therapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC), NexImmune (NASDAQ:NEXI) and Biophytis (NASDAQ:BPTS).
What is the target price for Windtree Therapeutics (WINT) stock?
The latest price target for Windtree Therapeutics (NASDAQ: WINT) was reported by Oppenheimer on Friday, June 4, 2021. The analyst firm set a price target for 8.00 expecting WINT to rise to within 12 months (a possible 732.64% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Windtree Therapeutics (WINT)?
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $0.9608 last updated Today at September 22, 2023 at 6:05 PM UTC.
Does Windtree Therapeutics (WINT) pay a dividend?
There is no dividend information for Windtree Therapeutics.
When is Windtree Therapeutics (NASDAQ:WINT) reporting earnings?
Windtree Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Windtree Therapeutics (WINT) going to split?
There is no upcoming split for Windtree Therapeutics.
What sector and industry does Windtree Therapeutics (WINT) operate in?
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Windtree Therapeutics Stock (NASDAQ:WINT), Quotes and News Summary
Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
| Open0.981 | Close- |
| Vol / Avg.15.635K / 130.124K | Mkt Cap4.946M |
| Day Range0.940 - 1.000 | 52 Wk Range0.980 - 20.885 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -1.640 | -0.9600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-06-04 | Oppenheimer | Leland Gershell | Initiates Coverage On | Outperform | Announces | - | 8.00 |
| 2020-06-26 | Ladenburg Thalmann | Jeffrey Cohen | Initiates Coverage On | Buy | Announces | - | 12.25 |
| 2017-06-30 | Stifel | Thomas Shrader | Downgrades | BuyHold | - | - | - |
| 2016-04-22 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| WINT | Windtree Therapeutics | -2.06% | 4.9M |
| QNRX | Quoin Pharmaceuticals | -4% | 4.7M |
| ADXN | Addex Therapeutics | -10.03% | 5.6M |
| CYCC | Cyclacel Pharmaceuticals | -5.33% | 4M |
| NEXI | NexImmune | -3.43% | 5.3M |
How do I buy Windtree Therapeutics (WINT) stock?
You can purchase shares of Windtree Therapeutics (NASDAQ: WINT) through any online brokerage.
Who are Windtree Therapeutics's (WINT) competitors?
Other companies in Windtree Therapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC), NexImmune (NASDAQ:NEXI) and Biophytis (NASDAQ:BPTS).
What is the target price for Windtree Therapeutics (WINT) stock?
The latest price target for Windtree Therapeutics (NASDAQ: WINT) was reported by Oppenheimer on Friday, June 4, 2021. The analyst firm set a price target for 8.00 expecting WINT to rise to within 12 months (a possible 732.64% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Windtree Therapeutics (WINT)?
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $0.9608 last updated Today at September 22, 2023 at 6:05 PM UTC.
Does Windtree Therapeutics (WINT) pay a dividend?
There is no dividend information for Windtree Therapeutics.
When is Windtree Therapeutics (NASDAQ:WINT) reporting earnings?
Windtree Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Windtree Therapeutics (WINT) going to split?
There is no upcoming split for Windtree Therapeutics.
What sector and industry does Windtree Therapeutics (WINT) operate in?
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Windtree Therapeutics Stock (NASDAQ:WINT), Quotes and News Summary
Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
| Open0.981 | Close- |
| Vol / Avg.15.635K / 130.124K | Mkt Cap4.946M |
| Day Range0.940 - 1.000 | 52 Wk Range0.980 - 20.885 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -1.640 | -0.9600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-06-04 | Oppenheimer | Leland Gershell | Initiates Coverage On | Outperform | Announces | - | 8.00 |
| 2020-06-26 | Ladenburg Thalmann | Jeffrey Cohen | Initiates Coverage On | Buy | Announces | - | 12.25 |
| 2017-06-30 | Stifel | Thomas Shrader | Downgrades | BuyHold | - | - | - |
| 2016-04-22 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| WINT | Windtree Therapeutics | -2.06% | 4.9M |
| QNRX | Quoin Pharmaceuticals | -4% | 4.7M |
| ADXN | Addex Therapeutics | -10.03% | 5.6M |
| CYCC | Cyclacel Pharmaceuticals | -5.33% | 4M |
| NEXI | NexImmune | -3.43% | 5.3M |
How do I buy Windtree Therapeutics (WINT) stock?
You can purchase shares of Windtree Therapeutics (NASDAQ: WINT) through any online brokerage.
Who are Windtree Therapeutics's (WINT) competitors?
Other companies in Windtree Therapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC), NexImmune (NASDAQ:NEXI) and Biophytis (NASDAQ:BPTS).
What is the target price for Windtree Therapeutics (WINT) stock?
The latest price target for Windtree Therapeutics (NASDAQ: WINT) was reported by Oppenheimer on Friday, June 4, 2021. The analyst firm set a price target for 8.00 expecting WINT to rise to within 12 months (a possible 732.64% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Windtree Therapeutics (WINT)?
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $0.9608 last updated Today at September 22, 2023 at 6:05 PM UTC.
Does Windtree Therapeutics (WINT) pay a dividend?
There is no dividend information for Windtree Therapeutics.
When is Windtree Therapeutics (NASDAQ:WINT) reporting earnings?
Windtree Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Windtree Therapeutics (WINT) going to split?
There is no upcoming split for Windtree Therapeutics.
What sector and industry does Windtree Therapeutics (WINT) operate in?
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Windtree Therapeutics Stock (NASDAQ:WINT), Quotes and News Summary
Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
| Open0.981 | Close- |
| Vol / Avg.15.635K / 130.124K | Mkt Cap4.946M |
| Day Range0.940 - 1.000 | 52 Wk Range0.980 - 20.885 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -1.640 | -0.9600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-06-04 | Oppenheimer | Leland Gershell | Initiates Coverage On | Outperform | Announces | - | 8.00 |
| 2020-06-26 | Ladenburg Thalmann | Jeffrey Cohen | Initiates Coverage On | Buy | Announces | - | 12.25 |
| 2017-06-30 | Stifel | Thomas Shrader | Downgrades | BuyHold | - | - | - |
| 2016-04-22 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| WINT | Windtree Therapeutics | -2.06% | 4.9M |
| QNRX | Quoin Pharmaceuticals | -4% | 4.7M |
| ADXN | Addex Therapeutics | -10.03% | 5.6M |
| CYCC | Cyclacel Pharmaceuticals | -5.33% | 4M |
| NEXI | NexImmune | -3.43% | 5.3M |
How do I buy Windtree Therapeutics (WINT) stock?
You can purchase shares of Windtree Therapeutics (NASDAQ: WINT) through any online brokerage.
Who are Windtree Therapeutics's (WINT) competitors?
Other companies in Windtree Therapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC), NexImmune (NASDAQ:NEXI) and Biophytis (NASDAQ:BPTS).
What is the target price for Windtree Therapeutics (WINT) stock?
The latest price target for Windtree Therapeutics (NASDAQ: WINT) was reported by Oppenheimer on Friday, June 4, 2021. The analyst firm set a price target for 8.00 expecting WINT to rise to within 12 months (a possible 732.64% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Windtree Therapeutics (WINT)?
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $0.9608 last updated Today at September 22, 2023 at 6:05 PM UTC.
Does Windtree Therapeutics (WINT) pay a dividend?
There is no dividend information for Windtree Therapeutics.
When is Windtree Therapeutics (NASDAQ:WINT) reporting earnings?
Windtree Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Windtree Therapeutics (WINT) going to split?
There is no upcoming split for Windtree Therapeutics.
What sector and industry does Windtree Therapeutics (WINT) operate in?
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Windtree Therapeutics Stock (NASDAQ:WINT), Quotes and News Summary
Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
| Open0.981 | Close- |
| Vol / Avg.15.635K / 130.124K | Mkt Cap4.946M |
| Day Range0.940 - 1.000 | 52 Wk Range0.980 - 20.885 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -1.640 | -0.9600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-06-04 | Oppenheimer | Leland Gershell | Initiates Coverage On | Outperform | Announces | - | 8.00 |
| 2020-06-26 | Ladenburg Thalmann | Jeffrey Cohen | Initiates Coverage On | Buy | Announces | - | 12.25 |
| 2017-06-30 | Stifel | Thomas Shrader | Downgrades | BuyHold | - | - | - |
| 2016-04-22 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| WINT | Windtree Therapeutics | -2.06% | 4.9M |
| QNRX | Quoin Pharmaceuticals | -4% | 4.7M |
| ADXN | Addex Therapeutics | -10.03% | 5.6M |
| CYCC | Cyclacel Pharmaceuticals | -5.33% | 4M |
| NEXI | NexImmune | -3.43% | 5.3M |
How do I buy Windtree Therapeutics (WINT) stock?
You can purchase shares of Windtree Therapeutics (NASDAQ: WINT) through any online brokerage.
Who are Windtree Therapeutics's (WINT) competitors?
Other companies in Windtree Therapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC), NexImmune (NASDAQ:NEXI) and Biophytis (NASDAQ:BPTS).
What is the target price for Windtree Therapeutics (WINT) stock?
The latest price target for Windtree Therapeutics (NASDAQ: WINT) was reported by Oppenheimer on Friday, June 4, 2021. The analyst firm set a price target for 8.00 expecting WINT to rise to within 12 months (a possible 732.64% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Windtree Therapeutics (WINT)?
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $0.9608 last updated Today at September 22, 2023 at 6:05 PM UTC.
Does Windtree Therapeutics (WINT) pay a dividend?
There is no dividend information for Windtree Therapeutics.
When is Windtree Therapeutics (NASDAQ:WINT) reporting earnings?
Windtree Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Windtree Therapeutics (WINT) going to split?
There is no upcoming split for Windtree Therapeutics.
What sector and industry does Windtree Therapeutics (WINT) operate in?
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Windtree Therapeutics Stock (NASDAQ:WINT), Quotes and News Summary
Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
| Open0.981 | Close- |
| Vol / Avg.15.635K / 130.124K | Mkt Cap4.946M |
| Day Range0.940 - 1.000 | 52 Wk Range0.980 - 20.885 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -1.640 | -0.9600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-06-04 | Oppenheimer | Leland Gershell | Initiates Coverage On | Outperform | Announces | - | 8.00 |
| 2020-06-26 | Ladenburg Thalmann | Jeffrey Cohen | Initiates Coverage On | Buy | Announces | - | 12.25 |
| 2017-06-30 | Stifel | Thomas Shrader | Downgrades | BuyHold | - | - | - |
| 2016-04-22 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| WINT | Windtree Therapeutics | -2.06% | 4.9M |
| QNRX | Quoin Pharmaceuticals | -4% | 4.7M |
| ADXN | Addex Therapeutics | -10.03% | 5.6M |
| CYCC | Cyclacel Pharmaceuticals | -5.33% | 4M |
| NEXI | NexImmune | -3.43% | 5.3M |
How do I buy Windtree Therapeutics (WINT) stock?
You can purchase shares of Windtree Therapeutics (NASDAQ: WINT) through any online brokerage.
Who are Windtree Therapeutics's (WINT) competitors?
Other companies in Windtree Therapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC), NexImmune (NASDAQ:NEXI) and Biophytis (NASDAQ:BPTS).
What is the target price for Windtree Therapeutics (WINT) stock?
The latest price target for Windtree Therapeutics (NASDAQ: WINT) was reported by Oppenheimer on Friday, June 4, 2021. The analyst firm set a price target for 8.00 expecting WINT to rise to within 12 months (a possible 732.64% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Windtree Therapeutics (WINT)?
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $0.9608 last updated Today at September 22, 2023 at 6:05 PM UTC.
Does Windtree Therapeutics (WINT) pay a dividend?
There is no dividend information for Windtree Therapeutics.
When is Windtree Therapeutics (NASDAQ:WINT) reporting earnings?
Windtree Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Windtree Therapeutics (WINT) going to split?
There is no upcoming split for Windtree Therapeutics.
What sector and industry does Windtree Therapeutics (WINT) operate in?
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Windtree Therapeutics Stock (NASDAQ:WINT), Quotes and News Summary
Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
| Open0.981 | Close- |
| Vol / Avg.15.635K / 130.124K | Mkt Cap4.946M |
| Day Range0.940 - 1.000 | 52 Wk Range0.980 - 20.885 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -1.640 | -0.9600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-06-04 | Oppenheimer | Leland Gershell | Initiates Coverage On | Outperform | Announces | - | 8.00 |
| 2020-06-26 | Ladenburg Thalmann | Jeffrey Cohen | Initiates Coverage On | Buy | Announces | - | 12.25 |
| 2017-06-30 | Stifel | Thomas Shrader | Downgrades | BuyHold | - | - | - |
| 2016-04-22 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| WINT | Windtree Therapeutics | -2.06% | 4.9M |
| QNRX | Quoin Pharmaceuticals | -4% | 4.7M |
| ADXN | Addex Therapeutics | -10.03% | 5.6M |
| CYCC | Cyclacel Pharmaceuticals | -5.33% | 4M |
| NEXI | NexImmune | -3.43% | 5.3M |
How do I buy Windtree Therapeutics (WINT) stock?
You can purchase shares of Windtree Therapeutics (NASDAQ: WINT) through any online brokerage.
Who are Windtree Therapeutics's (WINT) competitors?
Other companies in Windtree Therapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC), NexImmune (NASDAQ:NEXI) and Biophytis (NASDAQ:BPTS).
What is the target price for Windtree Therapeutics (WINT) stock?
The latest price target for Windtree Therapeutics (NASDAQ: WINT) was reported by Oppenheimer on Friday, June 4, 2021. The analyst firm set a price target for 8.00 expecting WINT to rise to within 12 months (a possible 732.64% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Windtree Therapeutics (WINT)?
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $0.9608 last updated Today at September 22, 2023 at 6:05 PM UTC.
Does Windtree Therapeutics (WINT) pay a dividend?
There is no dividend information for Windtree Therapeutics.
When is Windtree Therapeutics (NASDAQ:WINT) reporting earnings?
Windtree Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Windtree Therapeutics (WINT) going to split?
There is no upcoming split for Windtree Therapeutics.
What sector and industry does Windtree Therapeutics (WINT) operate in?
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Windtree Therapeutics Stock (NASDAQ:WINT), Quotes and News Summary
Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
| Open0.981 | Close- |
| Vol / Avg.15.635K / 130.124K | Mkt Cap4.946M |
| Day Range0.940 - 1.000 | 52 Wk Range0.980 - 20.885 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.680 | -1.640 | -0.9600 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2021-06-04 | Oppenheimer | Leland Gershell | Initiates Coverage On | Outperform | Announces | - | 8.00 |
| 2020-06-26 | Ladenburg Thalmann | Jeffrey Cohen | Initiates Coverage On | Buy | Announces | - | 12.25 |
| 2017-06-30 | Stifel | Thomas Shrader | Downgrades | BuyHold | - | - | - |
| 2016-04-22 | HC Wainwright & Co. | - | Initiates Coverage On | Buy | Announces | - | 8.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| WINT | Windtree Therapeutics | -2.06% | 4.9M |
| QNRX | Quoin Pharmaceuticals | -4% | 4.7M |
| ADXN | Addex Therapeutics | -10.03% | 5.6M |
| CYCC | Cyclacel Pharmaceuticals | -5.33% | 4M |
| NEXI | NexImmune | -3.43% | 5.3M |
How do I buy Windtree Therapeutics (WINT) stock?
You can purchase shares of Windtree Therapeutics (NASDAQ: WINT) through any online brokerage.
Who are Windtree Therapeutics's (WINT) competitors?
Other companies in Windtree Therapeutics’s space includes: Quoin Pharmaceuticals (NASDAQ:QNRX), Addex Therapeutics (NASDAQ:ADXN), Cyclacel Pharmaceuticals (NASDAQ:CYCC), NexImmune (NASDAQ:NEXI) and Biophytis (NASDAQ:BPTS).
What is the target price for Windtree Therapeutics (WINT) stock?
The latest price target for Windtree Therapeutics (NASDAQ: WINT) was reported by Oppenheimer on Friday, June 4, 2021. The analyst firm set a price target for 8.00 expecting WINT to rise to within 12 months (a possible 732.64% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Windtree Therapeutics (WINT)?
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $0.9608 last updated Today at September 22, 2023 at 6:05 PM UTC.
Does Windtree Therapeutics (WINT) pay a dividend?
There is no dividend information for Windtree Therapeutics.
When is Windtree Therapeutics (NASDAQ:WINT) reporting earnings?
Windtree Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Windtree Therapeutics (WINT) going to split?
There is no upcoming split for Windtree Therapeutics.
What sector and industry does Windtree Therapeutics (WINT) operate in?
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.